Nonsurgical approaches to the management of thyroid nodules

Nature Clinical Practice Endocrinology and Metabolism

Volumn 2, Issue 7, 2006, Pages 384-394

  Filetti, Sebastiano ^a,d   Durante, Cosimo ^b   Torlontano, Massimo ^c  

^a Internal Medicine Department   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

Laser ablation; Levothyroxine; Percutaneous ethanol injection; Radioiodine; Thyroid nodule

Indexed keywords

ALCOHOL; ANALGESIC AGENT; CORTICOSTEROID; IODINE; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THYROID HORMONE; THYROXINE;

ANAMNESIS; ASPIRATION CYTOLOGY; BENIGN TUMOR; BONE DENSITY; CANCER DIAGNOSIS; CANCER SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; COMPRESSION; COST BENEFIT ANALYSIS; DIASTOLE; DISEASE CLASSIFICATION; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; ESTHETICS; EXPERIENCE; FOLLOW UP; GRAVES DISEASE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK POPULATION; HORMONE INHIBITION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; LABORATORY TEST; LASER COAGULATION; LASER SURGERY; LOW LEVEL LASER THERAPY; MEDICAL DOCUMENTATION; MORTALITY; NECK PAIN; NODULAR GOITER; PAIN; PALPATION; PHYSICAL EXAMINATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROBABILITY; PROPHYLAXIS; RADIATION INJURY; REMISSION; REVIEW; RISK ASSESSMENT; SCINTISCANNING; SIDE EFFECT; SINGLE DRUG DOSE; SUPPLEMENTATION; SYMPTOMATOLOGY; TACHYCARDIA; THYROID CANCER; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; THYROIDITIS; THYROTOXICOSIS; TOXIC GOITER; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT REFUSAL; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR RECURRENCE; ULTRASOUND; UNSPECIFIED SIDE EFFECT;

HUMANS; IODINE RADIOISOTOPES; THYROID NODULE; THYROXINE;

EID: 33745921752     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0215     Document Type: Review

References (80)

1. Vander JB et al. (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69: 537-540
2. Tunbridge WM et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7: 481-493
3. Mortensen JD et al. (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15: 1270-1280
4. Tan GH and Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126: 226-231
5. Ross DS (2002) Nonpalpable thyroid nodules - managing an epidemic. J Clin Endocrinol Metab 87: 1938-1940
6. Burguera B and Gharib H (2000) Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 29: 187-203
7. Bennedbæk FN et al. (1999) Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 50: 357-363
8. Bennedbæk FN and Hegedüs L (2000) Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 85: 2493-2498
9. Bonnema SJ et al. (2000) Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 53: 5-12
10. Bonnema SJ et al. (2002) Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 87: 112-117
11. Tan GH et al. (1995) Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 155: 2418-2423
12. Leenhardt L et al. (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14: 1056-1060
13. Hegedüs L et al. (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24: 102-132
14. American Cancer Society (2005) Cancer Facts and Figures 2005. Atlanta: American Cancer Society [www.cancer.org/downloads/STT/CAFF2005PWSecured4.pdf] (accessed 4 May 2006)
15. Hamburger JI (1994) Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 79: 335-339
16. Cooper DS et al. (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16: 1-33
17. Feld S et al. (1996) AACE clinical practice guidelines for the diagnosis and management of thyroid nodules. Endocr Pract 2: 78-84
18. Castro MR and Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142: 926-931
19. Rago T et al. (1998) Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol 138: 41-46
20. Papini E et al. (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87: 1941-1946
21. Jun P et al. (2005) The sonographic features of papillary thyroid carcinomas: pictorial essay. Ultrasound Q 21: 39-45
22. Schlumberger M et al. (2003) Non toxic goiter and thyroid neoplasia. In Williams' Textbook of Endocrinology, edn 10, 457-490 (Eds Larsen PR et al.) Philadelphia: WB Saunders
23. Kuma K et al. (1992) Outcome of long standing solitary thyroid nodules. World J Surg 16: 583-587
24. Quadbeck B et al. (2002) Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes 110: 348-354
25. Alexander EK et al. (2003) Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 138: 315-318
26. Costante G et al. (2004) Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. J Endocrinol Invest 27: 31-36
27. Wilders-Truschnig MM et al. (1993) The effect of treatment with levothyroxine or iodine on thyroid size and thyroid growth stimulating immunoglobulins in endemic goitre patients. Clin Endocrinol (Oxf) 39: 281-286
28. Hintze G and Kobberling J (1992) Treatment of iodine deficiency goiter with iodine, levothyroxine or a combination of both. Thyroidology 4: 37-40
29. Azizi F et al. (2005) Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 28: 23-29
30. Lewinski A et al. (2003) Iodine-induced hyperthyroidism - an epidemiological survey several years after institution of iodine prophylaxis in Poland. J Endocrinol Invest 26 (Suppl): 57-62
31. Biondi B et al. (2005) Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1: 32-40
32. Bruno R et al. (2005) Modulation of thyroid-specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin. J Clin Endocrinol Metab 90: 5692-5697
33. Surks MI et al. (2004) Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 291: 228-238
34. Biondi B et al. (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152: 1-9
35. Castro MR et al. (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87: 4154-4159
36. Gharib H et al. (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317: 70-75
37. Reverter J et al. (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36: 25-28
38. Papini E et al. (1993) A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38: 507-513
39. La Rosa G et al. (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122: 1-8
40. Zelmanovitz F et al. (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83: 3881-3885
41. Larijani B et al. (1999) Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double blind placebo-controlled clinical trial. Endocr Pract 5: 251-256
42. Werneau JL et al. (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87: 4928-4934
43. Papini E et al. (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83: 780-783
44. McCowen K et al. (1980) The role of thyroid therapy in patients with thyroid cysts. Am J Med 68: 853-855
45. La Rosa G et al. (1996) Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 81: 4385-4387
46. Lima N et al. (1997) Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7: 691-697
47. Kahaly GJ and Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26: 704-728
48. Biondi B et al. (2002) Mortality in elderly patients with subclinical hyperthyroidism. Lancet 359: 799-800
49. Uzzan B et al. (1996) Effects on bone mass of long-term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81: 4278-4289
50. Faber J and Galloe AM (1994) Changes in bone mass during prolonged subclinical hyperthyraidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 130: 350-356
51. Schneider R and Reiners C (2003) The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. Exp Clin Endocrinol Diabetes 111: 455-470
52. Koc M et al. (2002) Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57: 621-628
53. Chapman EM (1983) History of the discovery and early use of radioactive iodine. J Am Med Assoc 250: 2042-2044
54. Nygaard B et al. (1999) Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf) 50: 197-202
55. Nygaard B et al. (1999) Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 159: 1364-1368
56. Manders JMB and Corstens FHM et al. (2002) Radioiodine therapy of euthyroid multinodular goitres. Eur J Nucl Med Mol Imaging 29 (Suppl 2): S466-S470
57. Estour B et al. (1997) Efficacy of low doses of radioiodine in the treatment of autonomous thyroid nodules: importance of dose/area ratio. Thyroid 7: 357-361
58. Metso S et al. (2004) Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 61: 641-648
59. Erem C et al. (2004) Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome. Endocrine 25: 55-60
60. Nygaard B et al. (1993) Radioiodine treatment of multinodular non-toxic goitre. BMJ 307: 828-832
61. Huysmans D et al. (1997) Radioiodine for nontoxic multinodular goiter. Thyroid 7: 235-239
62. Albino CC et al. (2005) Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90: 2775-2780
63. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90: 79-83
64. Duick DS and Baskin HJ (2003) Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9: 204-209
65. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab 91: 506-510
66. Lippi F et al. (1996) Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab 81: 3261-3264
67. Bennedbaek FN and Hegedüs L (2003) Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 88: 5773-5777
68. Zingrillo M et al. (1999) Percutaneous ethanol injection may be a definitive treatment for symptomatic thyroid cystic nodules not treatable by surgery: five-year follow-up study. Thyroid 9: 763-767
69. Zingrillo M et al. (2000) Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study. Thyroid 10: 985-989
70. Del Prete S et al. (2002) Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid 12: 815-821
71. Guglielmi R et al. (2004) Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 14: 125-131
72. Valcavi R and Frasoldati A (2004) Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 10: 269-275
73. Bennedbæk FN et al. (1998) Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. J Clin Endocrinol Metab 83: 830-835
74. Bennedbæk FN and Hegedüs L (1999) Percutaneous ethanol injection therapy in benign solitary solid cold thyroid nodules: a randomized trial comparing one injection with three injections. Thyroid 9: 225-233
75. Pacella CM et al. (2000) Thyroid tissue: US-guided percutaneous interstitial laser ablation - a feasibility study. Radiology 217: 673-677
76. Spiezia S et al. (2003). Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 13: 941-947
77. Pacella CM et al. (2004) Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 232: 272-280
78. Papini E et al. (2004) Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract 10: 276-283
79. Dossing H et al. (2005) Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules - a randomised study. Eur J Endocrinol 152: 341-345
80. Demers LM et al. (2002) Laboratory support for the diagnosis and monitoring of thyroid disease. In The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines [http://www.nacb.org/lmpg/ thyroid_lmpg_pub.stm] (accessed 4 May 2006)